The global legal cannabis market is seeing exponential growth with every passing year. In 2020, the market size was valued at US$24.6 billion, with market analysts projecting market expansion at a compound annual growth rate of 14.3 percent from 2021 to 2028. With innovative cannabis products entering the market every day, the sky’s the limit for this industry.

One particular cannabis product that demonstrates huge growth potential is hashish. With deep roots in Asian and North African history, this powerful cannabis plant concentrate is amid a reinvention that blends old-world traditions with new-age technologies for modern consumers to enjoy and investors to capitalize on.

What is hashish and how is it made?

Hashish or “hash” is the cannabis extract produced through separating kief, the sticky, crystal-like substance at the head of the cannabis plant’s trichomes or mushroom-shaped glands found on the plant’s leaves, stems and calyxes. After filtering, the kief is pressed and heated to rupture its resin glands, ultimately changing the composition, which is later formed into a softball or brick.

This CEO Interview is brought to you by:

The Hash Corporation (CSE:REZN) is a Canadian company focused on the production of cannabis-based hashish and other premium cannabis products. Using the adaption of old-world traditions, the company aims to safely deliver authentic hashish experiences crafted to modern standards and regulations. Send me an Investor Kit

Modern separation of trichomes from cannabis buds involves a type of cold sieving to carefully remove and collect the trichomes in an efficient manner.

This potent concentrate has strong effects and a unique flavor, often ranging from golden yellow to dark brown or black in color depending on the method of production. As a purely mechanical process, hash production involves zero solvents like butane or propane, which can affect the taste and texture of the final product. For cannabis enthusiasts, hash is unlike anything else on the market.

The history of artisanal hashish

The history of hashish spans thousands of years. Some scholars place hash use as far as 900 AD, where it was widely popular in West Asia and still is today. This cannabis extract would be used in an array of applications from personal use for its “euphoriant properties,” royal offerings and more.

Even in the west, history finds appearances of hashish in Europe around the 18th century and later 19th century as a means of experimental medical use. As hash makes its way around the world, divergent methods in its production have created one-of-a-kind uses, euphoric effects and brilliant flavors unique to different parts of the world.

For example, in Moroccan and Afghan hash, producers use traditional sieving methods to separate trichomes from dried cannabis plant material. This helps yield the highest-quality kief for heating and pressing to give a potent concentrate.

Companies like The Hash Corporation (CSE:REZN) or HASHCO, utilize these old-world traditions in Moroccan and Afghan hashish production to safely deliver authentic hashish experiences and premium cannabis products crafted to modern standards and regulations. Their solvent-free process and collaborative approach with licensed cannabis cultivators embody the perfect blend of old and new for modern consumers.

Additionally, Indian hash or charas is produced by separating the trichomes by hand. Workers roll cannabis buds between their hands and the trichomes are removed through friction and heat, later formed into balls to give charas. With such a delicate and labor-intensive process, the exclusivity of this artisanal hash has begun to pique the interest of international cannabis users who are seeking something special outside of the typical joint of cannabis.

Hashish vs. cannabis

While most of the buzz surrounds large Canadian licensed producers like Tilray (TSX:TLRY,NYSE:TLRY) and Canopy Growth (TSX:WEED,NASDAQ:CGC), or American multi-state operators like Cresco Labs (TSVX:CL), Curaleaf Holdings (TSVX:CURA) and Trulieve Cannabis (TSVX:TRUL), hash products represent a significant opportunity in this growing industry.

Innovations in cannabis extraction and product development have created methods of cannabis consumption that offer more versatility than ever before. Like cannabis, hash can be enjoyed by smoking in a pre-rolled joint or through other accessories like extract-specific or dried flower vaporizers. When vaporized or dabbed, hash offers a smoke-free option to inhaling dried cannabis flower.

The biggest upside of hash is its high concentration of cannabinoids. Its potency can reach as high as 60 percent tetrahydrocannabinol or THC in comparison to estimated concentrations of 15 to 30 percent in cannabis. Hash users need to consume less for the sought-after effects of euphoria, relaxation and calmness that cannabis is known for.

In addition, the difference in processing both cannabis and hashish also lead to distinct end products and flavors. Cannabis, either grown indoors or outdoors, is harvested after seven to 11 weeks, when it is dried and cured to improve its maturity, potency and flavor. For hash, the amount of care and treatment needed to produce these extracts is evident in how uniquely complex, rich or spicy its flavor translates when consumed.

Investment opportunities in the growing global hashish market

Market researchers project the legal cannabis market to reach upwards of US$43 billion by 2025 in the US alone. As the high-potency alternative to cannabis and other lower-level THC cannabis products, hashish could hold a large portion of that pie.

Shifting legal frameworks surrounding cannabis have also contributed to a massive growth in predicted cannabis use throughout the world. With more countries opening up to the economic benefits of cannabis legalization, cannabis retailers and producers could see significant widening and diversification of distributed consumer bases to segment and target.

Morocco, Afghanistan and Lebanon, the world’s three largest exporters of hashish, have introduced proposals to legalize cannabis for medical use and a strategic economic powerplay to benefit farmers nationwide. With a well-established consumer base and competitive market conditions, hash could be the catalyst for where the hottest cannabis hubs stem from next.

Like HASHCO, Colorado-based cannabis and hash factory The Greenery has made strides in bringing this rich cannabis extract to western markets. With a diverse catalogue of kief bricks, Lebanese hash and modern bubble hash, these companies continue to blend tradition, artistry and technology for a high-quality hashish that is unlike anything on the market.

Especially as cannabis stakeholders look for innovative ways to consume and produce cannabis for rapidly expanding markets, hash presents the potential to disrupt cannabis markets in the west as it has in the east.


Hashish is a high-potency cannabis concentrate that has the potential to play a significant part in the growing global cannabis market. Companies like HASHCO are introducing premium hash to western markets where investors can gain an early mover advantage across shifting legal frameworks. Its rich history, artisanal mechanical separation and innovative solvent-free cannabinoid processing make hash a unique alternative to cannabis for evolving consumer bases around the world.

This INNSpired article is sponsored by The Hash Corporation (CSE:REZN). This INNSpired article provides information which was sourced by the Investing News Network (INN) and approved by The Hash Corporation in order to help investors learn more about the company. The Hash Corporation is a client of INN. The company’s campaign fees pay for INN to create and update this INNSpired article.

INN does not provide investment advice and the information on this profile should not be considered a recommendation to buy or sell any security. INN does not endorse or recommend the business, products, services or securities of any company profiled.

The information contained here is for information purposes only and is not to be construed as an offer or solicitation for the sale or purchase of securities. Readers should conduct their own research for all information publicly available concerning the company. Prior to making any investment decision, it is recommended that readers consult directly with The Hash Corporation and seek advice from a qualified investment advisor.

US cannabis received a boost this week with a policy move that may hint at future changes.

Meanwhile, Amazon (NASDQ:AMZN) threw its full support behind cannabis reform in the US by way of a public post confirming the company’s acceptance of the drug.

Keep reading... Show less
  • Research findings originated from cannabinoid-based collaboration with leading epilepsy researcher, Dr. Peter Carlen, at UHN that is also supported by a Mitacs Accelerate program grant.
  • Avicanna’s proprietary formulation showed promising pre-clinical results in reducing seizures and will be developed through the company’s pharmaceutical development pipeline as an epilepsy drug candidate.


Avicanna Inc. (” Avicanna ” or the ” Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based pharmaceuticals is pleased to announce that it has filed a provisional patent application with the United States Patent and Trademark Office, entitled “Methods for Reducing or Eliminating Incidence of Seizures and Sudden Unexpected Death in Epilepsy”, on the use of a novel cannabinoid formulation (the “ Formulation Candidate ”).

Keep reading... Show less

Cannabis legalization in Canada helped kickstart a financial revolution in the stock market with the launch of a diverse portfolio of marijuana firms.

With the boom of public cannabis businesses in full swing, are you thinking about investing in cannabis companies? If so, consider starting your journey here.

A wide spectrum of marijuana stocks have made their mark in the global industry thanks to the amount of money raised from investors and the attention the sector is getting from established industries.


Cannabis Market Could Reach $5.5B By End Of Year

Experts Weigh In On Our Exclusive FREE Report. Can You Afford To Miss Out?

What’s to come is anyone’s guess, but it seems this new and burgeoning industry is still in its early days, with diverse nations beginning to move forward with plans for legalizing marijuana.

That means there’s likely still money to be made in cannabis stocks as the market builds and cannabis products expand in availability over the next few years.

There are many differing opinions about how much the global legal cannabis market will be worth in the years to come, with estimates including US$70.6 billion by 2028 and US$91.5 billion by that same year.

But one thing is almost certain: The market is set to grow as opinions surrounding the plant evolve over time and as platforms crop up to supply different consumption preferences. And all of that will mean more cannabis investment opportunities with both existing companies and future entries to the market.

For now, let’s take a look at where you can invest your money at this point in time.

How to invest in cannabis: Canadian cannabis stocks

First thing’s first: Canada. This is the obvious place to start as marijuana is legal at the federal level and Canadian cannabis stocks are less likely than their US counterparts to suffer from political volatility.

That said, due to the uncertainty of investing in the US marijuana space, where the drug is not legal at the federal level, Canadian firms have been forced to make choices about how they operate. For example, Canada’s senior exchanges do not allow companies with American cannabis assets to list.

While the Canadian cannabis space continues to face challenges, investors are eagerly watching as companies move into the edibles and beverages markets and develop new products.

For lists of Canadian marijuana stocks to consider, click here.


Cannabis Market Could Reach $5.5B By End Of Year

Experts Weigh In On Our Exclusive FREE Report. Can You Afford To Miss Out?

How to invest in cannabis: US cannabis stocks

Although some US states have legalized cannabis, American cannabis stocks may be riskier than those in Canada due to federal restrictions on the sale and cultivation of cannabis.

However, as the saying goes, the greater the risk, the greater the possible reward. The US market could grow up to US$43 billion by 2025, and that’s not even including the size of the market if nationwide legalization happens. It’s easy to see that US cannabis stocks could inherit a huge chunk of the pie if federal law finally legalizes the commodity.

All in all, picking the right US cannabis stocks could mean massive gains if the plant is ultimately legalized federally. It’s worthwhile for investors to do their research and to be aware of the risks and potential benefits involved in investing in the space.

For a list of US cannabis stocks to consider, click here.

How to invest in cannabis: A side note

Many companies in the cannabis space have begun to veer in one direction or another.

For example, some of the largest marijuana producers have moved towards deals with beverage or pharmaceutical companies for the production of novel new products. Others in the space continue to pursue innovation in the recreational market.

The beverage side in particular has seen interest from companies, with cannabis firms partnering with brew businesses. One example is Canopy Growth (NYSE:CGC,TSX:WEED), which has teamed up with Constellation Brands (NYSE:STZ), a leading producer in the alcoholic beverage industry.

It’s important to be aware that each niche has its own possibilities and challenges. For instance, while many market participants are convinced of the promise in beverages, these drinks have been hampered by strict marketing rules, among other factors.

Another aspect to consider is whether to pursue big caps or small caps. That has a lot to do with personal comfort. While big caps are often regarded as more stable than small caps, in the cannabis industry there’s been considerable volatility.


Cannabis Market Could Reach $5.5B By End Of Year

Experts Weigh In On Our Exclusive FREE Report. Can You Afford To Miss Out?

How to invest in cannabis: Cannabis ETFs

If you really know your cannabis companies, then you could enjoy larger gains by simply investing in those specific firms. However, if you aren’t overly familiar with the cannabis space or you are new to it, it could be a good idea to check out the cannabis exchange-traded funds (ETFs) available.

A cannabis ETF gives you exposure to several different cannabis stocks and takes the guesswork out of cherry picking which stock to bet on. One issue with ETFs is that like any other group dynamic, if one stock drops off it brings the whole fund down proportionally with it. Of course, the opposite is also true.

Recently investors have seen the addition of new ETFs offering exposure to the US market, including firms with entries into the hemp space, thanks to the sales of CBD products.

For a list of cannabis ETFs to consider, click here.

How to invest in cannabis: Final thoughts

No matter which way you slice it — or grind it, in this case — the cannabis market is an exciting business to invest in right now. Whether you invest in cannabis ETFs or Canadian or US marijuana stocks, or if you’re still waiting on the sidelines for more maturity from the types of cannabis companies trading, this industry is one to watch, and one that looks like it’ll keep climbing in the future.

Keep reading... Show less

TransCanna (CSE: TCAN) (FSE: TH8) (“the Company”) is pleased to announce that plants are going into its first crop management site today – a greenhouse in Wesley, California.

The Company partnered with the 3rd generation cannabis farmers at 365 CannaFarms to consult on the construction of the state-of-the-art, computer-controlled greenhouse and to help manage the crop for the client, Central Valley Growers. The entire crop is comprised of premium genetic strains from Lyfted Farms, TransCanna‘s wholly-owned subsidiary.

Keep reading... Show less

Acquisition strengthens clinic portfolio for mental health treatment using psychedelic-assisted therapies

Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced it has closed its acquisition of the Neurology Centre of Toronto (NCT), a leading Canadian provider of clinical neurologic care. The purchase agreement was previously announced on July 6, 2021 .

Keep reading... Show less